We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Informed Managed Care Decision-Making in the Treatment and Management of Ovarian Cancer: Optimizing the Impact of PARP Inhibitors for Improved Outcomes.
- Authors
Moore, Kathleen N.
- Abstract
Poly (ADP-ribose) polymerase (PARP) inhibitors for maintenance and treatment of advanced ovarian cancer has led to significant changes in the treatment paradigm for this disease. First-line maintenance therapy with PARP inhibitors with or without bevacizumab after platinum-based chemotherapy response is improving progression-free survival (PFS) which will hopefully translate to continued improvements in overall survival.
- Subjects
THERAPEUTIC use of antineoplastic agents; COMBINATION drug therapy; CONTINUING education units; MANAGED care programs; OVARIAN tumors; ENZYME inhibitors; BEVACIZUMAB; DECISION making in clinical medicine; TREATMENT effectiveness; CANCER chemotherapy; PROGRESSION-free survival; PLATINUM; OVERALL survival
- Publication
Journal of Managed Care Medicine, 2024, Vol 27, Issue 2, p36
- ISSN
1094-1525
- Publication type
Article